Early penetration of the blood-brain-barrier by HIV

Neurology

Volumn 38, Issue 1, 1988, Pages 9-14

  Resnick, Lionel ^a   Berger, Joseph R ^b   Shapshak, Paul ^c,d   Tourtellotte, Wallace W ^c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CEREBROSPINAL FLUID; DEMENTIA; FEMALE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; VIRUS;

ADULT; ANTIBODIES, VIRAL; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; FEMALE; HIV; HIV ANTIBODIES; HIV SEROPOSITIVITY; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; MALE; MIDDLE AGE; NERVOUS SYSTEM DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TIME FACTORS;

EID: 0023866331     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.1.9     Document Type: Article

References (32)

1. Koppel BS, Wormser GP, Tuchman AJ, Maayan S, Hewlett DJ, Daras C. Central nervous system involvement in patients with acquired immune deficiency syndrome (AIDS). Acta Neurol Scand 1985;71:337–353.
2. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS); experience at UCSF and review of the literature. J Neurosurg 1985;62:475–495.
3. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka C, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14:403–418.
4. Shaw CM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177–182.
5. Stoler MH, Eskin TA, Benn S, et al. Human T-cell lymphotrophic virus type III infection of the central nervous system: a preliminary in situ analysis. JAMA 1986;256:2360–2364.
6. Gabuzda DH, Ho DD, delaMonte S, Hirsch MS, Rota TR, Sobel RA. Immunohistuchemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289–295.
7. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517–524.
8. Navia BA, Cho E-S, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525–535.
9. Petito CK, Navia BA, Cho E-S, Jordan BD, George DC, Price RW. Vacuolar myelopathy: pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874–879.
10. Carne CA, Smith A, Elkington SG, et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985;2:1206–1208.
11. Berger J, Bender A, Resnick L, Perlmutter D. Spinal myoclonus associated with HTLV-III/LAV infection. Arch Neurol 1986;43:1203–1204.
12. Berger J, Resnick L. HTLV-III/LAV related neurological disorders. In: Broder S, ed. AIDS: modern concepts and therapeutic challenges. New York: Marcel Dekker, 1987:263–283.
13. Przedborski S, Liesnard C, Hildebrand J. HTLV-III and vacuolar myelopathy. N Engl J Med 1986;315:63.
14. Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 1985;2:586–588.
15. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493–1497.
16. Fauci AS, Macher AM, Longo DL, et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984;100:92–106.
17. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-111) from patients with AIDS and at risk for AIDS. Science 1984;224:500–503.
18. Resnick L, Novatt G. Human T-cell lymphotropic viruses: syncytia formation. JAMA 1986;255:3421.
19. Resnick L, diMarzo-Veronese F, Schupbach J, et al. Intra-blood-brain-barrier synthesis of HTLV-III specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 1985;313:1498–1504.
20. Staugaitis SM, Shapshak P, Tourtellotte WW, Lee MM, Reiber H-OO. Isoelectric focusing of unconcentrated cerebrospinal fluid applications to ultrasensitive analysis of oligoclonal immunoglobulin G. Electrophoresis 1985;6:287–291.
21. Tourtellotte WW, Tavolato B, Parker JA, Comiso P. Cerebrospinal fluid electroimmunodiffusion: an easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin. Arch Neurol 1971;25:345–350.
22. Tourtellotte WW, Potvin AR, Fleming JO, et al. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 1980;30:240–244.
23. Resnick L, Veren K, Salahuddin S, Tondreau S, Markham P. Stability of HTLV-III under commonly encountered clinical and laboratory environments and its inactivation by standard disinfectants. JAMA 1986;255:1887–1891.
24. Goudsmit J, DeWolf F, Paul DA, et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986;2:177–180.
25. Salahuddin SZ, Markham PD, Popovic M, et al. Isolation of infectious human T-cell leukemia/lymphotropic virus type-III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci USA 1985;82:5530–5534.
26. Schupbach J, Haller O, Vogt M, et al. Antihodies to HTLV-III in Swiss patients with AIDS or pre-AIDS and in groups at risk for AIDS. N Engl J Med 1985;312:265–270.
27. Ho DD, Sarngadharan MG, Resnick L, diMarzo-Veronese F, Rota T, Hirsch M. Primary human T-lymphotropic virus type III infection. Ann Intern Med 1985;103:880–883.
28. Resnick L, Shapshak P. Serological characterization of HIV infection by Western blot and radioimmunoprecipitation assays. Arch Pathol Lab Med 1987;111:1040–1044.
29. Griffin DE, Narayan O, Bukowski JF, Adams RJ, Cohen SR. The cerebrospinal fluid in visna, a slow viral disease of sheep. Ann Neurol 1978;4:212–218.
30. Koenig S, Gendelman E, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089–1093.
31. Gartner S, Markovits P, Markovitz DM, et al. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986;256:2365–2371.
32. Hollander H, Levy JA. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med 1987;106:692–695.